FRANKLIN, Mass. — New England Treatment Access (NETA) announced today that the cannabis company will be formally opening its 3rd retail store in Franklin, MA on Saturday, December 4th, 2021, at 8:00 a.m. The 10,000 square foot space, which includes retail, warehouse, and offices, is located at 162 Grove St. Franklin is also home to NETA’s cultivation and processing facility and the company’s headquarters, both located on Forge Parkway.
A ribbon cutting ceremony was held today at noon with local and state officials and the grand opening event will take place on Saturday, December 4th. We look forward to the Franklin community joining us for our celebration.
NETA has hired more than 60 employees for the new store, which will offer the same high-quality products that the company provides at its other two locations, in Brookline and Northampton. The Franklin store will be open Monday through Saturday 8:00 a.m. to 9:00 p.m. and Sunday 9:00 a.m. to 9:00 p.m. EDT. The new site provides over 100 parking spaces for patients and customers.
For the first 30 days of operation, it will be reserve ahead only for patients and customers and after that point NETA will offer in-person as well as reserve ahead options.
NETA is a division of the privately held, multi-state cannabis company Parallel and a leading cannabis operator in Massachusetts, being among the first to offer medical and adult-use cannabis to patients and customers in the state.
This announcement follows NETA’s launch of adult use delivery in partnership with Your Green Package, a majority women and Black owned social equity licensee, and is one of the first companies to deliver cannabis in the state.
“We want to thank the Cannabis Control Commission for its continuing support of the cannabis industry. We are thrilled to be able to offer patients and customers in the greater Franklin area easy access to us. We want to thank the Franklin community and its town leaders for welcoming us so warmly,” said Brad Doyle, NETA President. “Route 495 makes it convenient to reach us using either the Route 140 or King Street exits.”
Patients and customers will be able to purchase a variety of premium flower and pre-rolls, edibles, vaporizers, concentrates and more, from an array of Parallel’s top-quality brands.
New England Treatment Access (NETA) (www.netacare.org), a division of the privately held, multi-state cannabis company Parallel, is the leading vertically integrated cannabis company in Massachusetts. Founded by industry pioneers whose roots in regulated cannabis date to 2009, NETA’s licenses encompass medical and adult-use retail operations in Brookline and Northampton and soon to be opened in Franklin with cultivation and processing facilities also in Franklin. Across the organization, NETA employs 550 individuals and produces more than 435 unique SKUs. NETA conducted the first legal adult use sale of cannabis east of the Mississippi in 2018 and has provided cutting edge therapies and best in class services to our customers in Massachusetts since 2015.
- Commentary: It’s time for Biden to keep his promises on cannabisPaul Armentano, the deputy director of the National Organization for the Reform of Marijuana Laws (NORML), calls on President Joe Biden to live up to the pledges made during his campaign regarding cannabis legalization.
- Unofficial totals show Missouri cannabis legalization initiative shortAn initiative to legalize recreational marijuana use in Missouri will need help if it is going to be on the November ballot. Reports from every county in the state show the petition is short of its goal in two of the six congressional districts needed to qualify for the ballot.
- Fate of Missouri cannabis initiative unclear as signature count continuesWhether Missouri voters will get a chance to legalize recreational marijuana in November is still in question. The latest incomplete tabulations show the Legal Missouri 2022 initiative is short of the necessary signatures in four of the six Congressional districts necessary to make the ballot.
- ACLU of NV suit to deschedule cannabis statewide survives challengeA legal effort by the ACLU of Nevada to force the Nevada Board of Pharmacy to remove cannabis from its Schedule 1 of controlled substances will proceed, Clark County Judge Joe Hardy ruled Wednesday when he denied the board’s motion to dismiss the ACLU’s lawsuit.
- Advocates, parents ‘beg’ Nebraskans to seek out and sign petition to legalize medical cannabisAdvocates for legalizing medical marijuana switched Wednesday from urging Nebraskans to sign their petition to begging them as a July 7 deadline looms to submit signatures to qualify for the ballot in November.
- Iowans launch cannabis reform campaign aimed at showing public supportRobert “Lewy” Lewis of Windsor Heights has been in pain since 1974, when he had spinal surgery at the age of 21. To repair a blockage in his spine, surgeons removed eight inches of his vertebrae and then sewed them back on, using about 300 steel stitches.
- Big Apple Cannabis: CWCB Returns to New York City for Eighth Year“No one seems to have gotten it right.” Mayor Eric Adams told a Friday afternoon crowd, of legal cannabis in America. “This is our chance to get it right.” New York City’s mayor addressed attendees of the 2022 Cannabis World Congress & Business Expo (CWCBExpo) on the second day of the three-day event. Adams stressed the social equity focus of New York’s cannabis program.
- Nebraska medical cannabis backers file legal challenge to petition processSupporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot.
- N.J. lawmakers seek to curb cannabis useAs New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job.
- Missouri House votes to require disclosure of medical cannabis ownership recordsThe Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view.